| Exploring the Pharmacological Potentials of Biosurfactant Derived from Planococcus maritimus SAMP MCC 3013 S Waghmode, S Swami, D Sarkar, M Suryavanshi, S Roachlani, ... Current Microbiology 77, 452-459, 2020 | 31 | 2020 |
| Molecular modeling studies and in vitro screening of dihydrorugosaflavonoid and its derivatives against Mycobacterium tuberculosis NV Puranik, P Srivastava, S Swami, A Choudhari, D Sarkar RSC advances 8 (19), 10634-10643, 2018 | 15 | 2018 |
| The first synthesis of podocarflavone A and its analogs and evaluation of their antimycobacterial potential against Mycobacterium tuberculosis with the support of virtual screening NV Puranik, S Swami, AV Misar, R Mamgain, SS Gulawani, D Sarkar, ... Natural Product Research, 2021 | 7 | 2021 |
| Detection of a target protein (GroEl2) in Mycobacterium tuberculosis using a derivative of 1,2,4-triazolethiols DS Sampa Sarkar,Sagar Swami,Sarvesh Kumar Soni,Jessica K. Holien,Arshad Khan ... Molecular Diversity, 2021 | 3 | 2021 |
| Design, Synthesis, and in vitro Biological Evaluation of ROS‐Generating Phenanthridin‐trione‐Epoxide Conjugates as Agents against Mycobacterium tuberculosis R Mamgain, S Swami, D Sarkar, P Srivastava ChemistrySelect 8 (25), e202300416, 2023 | 1 | 2023 |
| Biological evaluation of novel small molecule inhibitors against Mycobacterium tuberculosis S Swami CSIR-National Chemical Laboratory, Pune, 2022 | | 2022 |
Dhiman SarkarEx-Chief Scientist, CSIR-National Chemical Laboratory, Pune, India在 ncl.res.in 的电子邮件经过验证
